Pro re nata medication for psychoses: The knowledge and beliefs of doctors and nurses

Australian and New Zealand Journal of Psychiatry

Volumn 36, Issue 5, 2002, Pages 642-648

  Geffen, Josh ^a   Cameron, Allison ^a   Sorensen, Lene ^a   Stokes, Julie ^a   Roberts, Michael S ^a   Geffen, Laurence ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Attitudes; Knowledge; Medication; Pro re nata; Psychosis; Survey

Indexed keywords

BENZODIAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DIAZEPAM; HALOPERIDOL; NEUROLEPTIC AGENT; OXAZEPAM; PSYCHOTROPIC AGENT; THIORIDAZINE;

AGITATION; ANXIETY NEUROSIS; ARTICLE; CONTINUING EDUCATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG USE; DYSPHORIA; GOOD CLINICAL PRACTICE; HALLUCINATION; HOSPITAL PATIENT; HUMAN; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL STAFF; MENTAL HEALTH SERVICE; NURSE ATTITUDE; NURSING STAFF; PHYSICIAN ATTITUDE; PRESCRIPTION; PSYCHOSIS; PUBLIC HOSPITAL; QUESTIONNAIRE; SLEEP DISORDER; SUICIDAL BEHAVIOR; SYMPTOM; THOUGHT DISORDER;

ANTIPSYCHOTIC AGENTS; COGNITION; CULTURE; DECISION MAKING; DRUG ADMINISTRATION SCHEDULE; HUMANS; NURSES; PHYSICIANS; PSYCHIATRY; PSYCHOTIC DISORDERS; QUESTIONNAIRES;

EID: 0036799166     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2002.01068.x     Document Type: Article

References (28)

1. Blair D. The placebogenic phenomenon: art in psychiatric nursing. Journal of Psychosocial Nursing and Mental Health Services 1996; 34:39-40.
2. Craig T, Bracken J. An epidemiological study of prn/stat medication use in a state psychiatric hospital. Annals of Clinical Psychiatry 1995; 7:57-64.
3. Craven J, Voore P, Voineskos G. Prn medication for psychiatric inpatients. Canadian Journal of Psychiatry 1986; 32:199-203.
4. Mason A, De Wolfe A. Usage of psychotropic drugs in a state mental hospital: 1. As needed (prn) antipsychotic medications. Current Therapeutic Research 1974; 16:853-860.
5. Kane J. Schizophrenia. New England Journal of Medicine 1996; 334:34-41.
6. Collaborative Working Group on Clinical Trial Evaluation. Assessment of EPS and Tardive Dyskinesia in Clinical Trials. Journal of Clinical Psychiatry 1998; 59 (Suppl. 12):23-27.
7. Kane J. Management Strategies for the Treatment of Schizophrenia. Journal of Clinical Psychiatry 1999; 60 (Suppl. 12):13-17.
8. Ayd F. Problems with orders for medication as needed. American Journal of Psychiatry 1985; 142:939-942.
9. Fishel A, Ferreiro B, Rynerson M, Nickel M, Jackson B, Hannah B. As needed psychotropic medications: prevalence indications and results. Journal of Psychosocial Nursing 1994; 32:27-32.
10. Walker R. PRN psychotropic drug use on a psychiatric unit. Psychiatric Quarterly 1991; 62:1-8.
11. Garza-Trevino E, Hollister L, Overall J, Alexander W. Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation. American Journal of Psychiatry 1989; 146:1599-1601.
12. Battaglia J, Moss S, Rush J et al. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double blind emergency department study. American Journal of Emergency Medicine 1997; 15:335-340.
13. Salzman C, Solomon D, Miyawaki E, Glassman R, Rood L, Flowers E. Parenteral lorazepam vs parenteral haloperidol for the control of psychotic disruptive behaviour. Journal of Clinical Psychiatry 1991; 52:177-180.
14. Foster S, Kessel J, Berman M, Simpson G. Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting. International Clinical Psychopharmacology 1997; 12:175-179.
15. Dubin W. Rapid tranquillisation: antipsychotics or benzodiazepines. Journal of Clinical Psychiatry 1988; 49 (Suppl.):5-10.
16. RANZCP Committee on Psychotropic Drugs and Other Physical Treatments. Response to 'Cardiotoxicity associated with the use of intravenous haloperidol' (letter). Australian and New Zealand Journal of Psychiatry 1999; 33:943-944.
17. Janicak P, Davis M, Preskhorn S, Ayd F. Treatment with antipsychotics. In: Janicak P, Davis M, Preskhorn S, Ayd F. Principles and practice of psychopharmacotherapy. Baltimore: Williams & Wilkins, 1993; 93-184.
18. Bazire S. Drug treatment options in psychiatric illness. In: Bazire S. Psychotropic drug directory 1999. Salisbury: Mark Allen Publishing, 1999; 1-115.
19. Soares K, McGrath J. The treatment of tardive dyskinesia: a systematic review and meta-analysis. Schizophrenia Research 1999; 39:1-16.
20. Jacobson D, Winograd C. Psychoactive medications in the long term care setting: differing perspectives among physicians, nursing staff and patients. Journal of Geriatric Psychiatry and Neurology 1994; 7:176-183.
21. Geffen J, Sorensen L, Stokes J, Cameron A, Roberts MS, Geffen L. PRN medication for psychoses: an audit of practice in two metropolitan hospitals. Australian and New Zealand Journal of Psychiatry 2002; 36:649-656.
22. Wolkowitz O, Pickar D. Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. American Journal of' Psychiatry 1991; 148:714-726.
23. Smythe M. Patient-controlled analgesia: a review. Pharmacotherapy 1992; 12:132-143.
24. Williams C. Patient-controlled analgesia: a review of the literature. Journal of Clinical Nursing 1996; 5:139-147.
25. Campbell R, Simpson G. Alternative approaches in the treatment of psychotic agitation. Psychosomatics 1986; 27 (Suppl. 1): 23-26.
26. Kibbe D, Kaluzny A, McLaughlin C. Integrating guidelines with continuous quality improvement: doing the right thing the right way to achieve the right goals. Journal of Quality Improvement 1994; 20:181-191.
27. Mort J, Singh Y, Gaspar P, Adams P, Singh N. Attitudes and knowledge of long term care nurses toward psychotropic medication in the elderly. Clinical Gerontologist 1993; 13:13-31.
28. Glasspoole L, Aman M. Attitudes and knowledge of gerontological nurses toward psychotropic drugs. Gerontologist 1988; 28:667-671.